Skip to content

Crystalloids versus colloids for goal-directed fluid therapy in gastrointestinal surgery

Crystalloids versus colloids for goal-directed fluid therapy in gastrointestinal surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-TNRC-14004479
Enrollment
Unknown
Registered
2014-03-01
Start date
2011-07-11
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gastric, colonic or rectal cancer

Interventions

Balanced colloid solution therapy:Volume optimization: Three bolus infusion of 3ml/kg of 6% Hydroxyethyl starch 130/40 over 7min Volume maintenance: 6% Hydroxyethyl starch 130/40 at rate of 0.2ml/kg/h
Balanced mixing colloid and crystalloid solution therapy:Volume optimization: Three bolus infusion of 3ml/kg of Ringer’s lactate solution over 7min Volume maintenance: Ringer’s lactate solution at rat
Balanced crystalloid solution therapy:Three bolus infusion of 3ml/kg of 6% Hydroxyethyl starch over 7mins Volume maintenance: Ringer’s lactate solution at rate of 0.2ml/kg/h
Balanced mixing colloid and crystalloid solution therapy:Preloading: 500ml of Ringer’s lactate solution over 2 h, beginning 3 h before induction of anesthesia Volume optimization: Three bolus infusion

Sponsors

the First affiliated Hospital, college of Medicine, Zhejiang University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
25 Years to 75 Years

Inclusion criteria

Inclusion criteria: patients scheduled for elective laparoscopic or open gastrointestinal surgery performed under intravenous general anaesthesia were recruited to participate in the study

Exclusion criteria

Exclusion criteria: Exclusion criteria were liver or renal dysfunction (liver enzymes >50% or serum creatinine >50% of normal), coagulation disturbances, obstructive pulmonary disease (airway pressure >25mmHg), atrial fibrillation, and mental disorders.

Design outcomes

Primary

MeasureTime frame
In-hospital post-operative complications of any cause (censored at 30 days following surgery);

Secondary

MeasureTime frame
Preoperative volume status and haemodynamic response to induction of general anesthesia;Blood volume of efficiency of starch and Ringer solution;Urine index during surgery;Duration of hospital stay after surgery;

Countries

China

Contacts

Public ContactYuhong Li

Shaoxing People's Hospital

yuh_li@qq.com+86 13758147990

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 9, 2026